Rebecca Pulk
Rebecca Pulk publishes mostly in Oncology, Immunology and Pediatrics, Perinatology and Child Health, on topics such as Cytokine Signaling Pathways and Interactions, Pharmacogenetics and Drug Metabolism and Pharmaceutical studies and practices.
- World rank
- #3,166,062 of 7,710,434 ranked researchers
- Rank in United States
- #901,183 of 1,627,098
- Works
- 30
- Citations
- 801
- Citations per work
- 26.7
What does Rebecca Pulk research?
Rebecca Pulk's work is mostly in Medicine (22%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1756.4%
- Health Sciences721.8%
- Medicine721.8%
- Life Sciences414.9%
- Social Sciences26.9%
- 1Oncology9% of their works
- 2Immunology8% of their works
- 3Pediatrics, Perinatology and Child Health7% of their works
- 4Molecular Biology7% of their works
- 5Economics and Econometrics7% of their works
- 6Genetics6% of their works
Research topics
- Cytokine Signaling Pathways and Interactions
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical studies and practices
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Melanoma and MAPK Pathways
- Psoriasis: Treatment and Pathogenesis
Which keywords describe Rebecca Pulk's research?
The keywords of their largest research topics: Immune Response, IL-6, STAT3, Cytochrome P450, Off-Label Drug Use, Pediatric Pharmacokinetics, Pharmacogenetics and Cost-effectiveness Analysis.
- MAP Kinase
- BRAF gene
- Polypharmacy
- JAK2 Mutation
- Cost-effectiveness Analysis
- Pediatric Pharmacokinetics
- Cytochrome P450
- IL-6
- Immune Response
- STAT3
- Off-Label Drug Use
- Pharmacogenetics
- Inappropriate Medication Use
- Myelofibrosis
- Quality of Life
- IL-17
- TH17 Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Immune Response82 topics
- IL-661 topic
- STAT361 topic
- Cytochrome P45051 topic
- Off-Label Drug Use51 topic
- Pediatric Pharmacokinetics51 topic
- Pharmacogenetics51 topic
- Cost-effectiveness Analysis41 topic
- Inappropriate Medication Use41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Polypharmacy41 topic
- Quality of Life41 topic
- BRAF gene21 topic
- IL-1721 topic
- MAP Kinase21 topic
- TH17 Cells21 topic
Where does Rebecca Pulk work?
Rebecca Pulk's main affiliation in the publication record is Yale New Haven Health System, United States.
How many publications and citations does Rebecca Pulk have?
OpenAlex counts 30 works and 801 citations for Rebecca Pulk, an h-index of 15, ranking #3,166,062 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rebecca Pulk. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.